Showing results (2101-2110 of 5,145) with videos related to
Sort By:
Pageof 515
Vox Sanguinis|April 26, 2007
Second-generation nanofiltered plasma-derived mannan-binding lectin product: process and characteristicsI Laursen, G Houen, P Højrup, et al.Vox Sanguinis|April 26, 2007
Effect of changing the age criteria for blood donorsM Goldman, E Fournier, K Cameron-Choi, et al.Vox Sanguinis|April 26, 2007
Real-time multiplex allele-specific polymerase chain reaction for genotyping of the Duffy antigen, the Plasmodium vivax invasion receptorT N Sousa, B A M Sanchez, I P Cerávolo, et al.Vox Sanguinis|March 14, 2007
Antibody therapy (IVIG): evaluation of the use of genomics and proteomics for the study of immunomodulation therapeuticsC V Sapan, H M Reisner, R L LundbladVox Sanguinis|July 1, 1977
Intensive plasmapheresis as a risk factor for arteriosclerotic cardiovascular disease?P Lundsgaard-HansenVox Sanguinis|June 23, 2009
Variant Creutzfeldt-Jakob disease and exposure to fractionated plasma productsH J T Ward, J M MacKenzie, C A Llewelyn, et al.Vox Sanguinis|August 22, 2009
A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experienceL Abbruzzese, M Michieli, M Rupolo, et al.Vox Sanguinis|August 22, 2009
Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegativeD Smith, Q Lu, S Yuan, et al.Vox Sanguinis|August 7, 2009
A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte-depleted red blood cellsC So-Osman, R Nelissen, R Te Slaa, et al.Vox Sanguinis|August 8, 2009
Intravenous immunoglobulin G: trends in production methods, quality control and quality assuranceM Radosevich, T BurnoufPageof 515